305 related articles for article (PubMed ID: 30251653)
1. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate.
Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653
[TBL] [Abstract][Full Text] [Related]
2. (-)-epigallocatechin-3-gallate inhibits fibrillogenesis of chicken cystatin.
Wang N; He J; Chang AK; Wang Y; Xu L; Chong X; Lu X; Sun Y; Xia X; Li H; Zhang B; Song Y; Kato A; Jones GW
J Agric Food Chem; 2015 Feb; 63(5):1347-51. PubMed ID: 25620201
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains.
Hora M; Carballo-Pacheco M; Weber B; Morris VK; Wittkopf A; Buchner J; Strodel B; Reif B
Sci Rep; 2017 Jan; 7():41515. PubMed ID: 28128355
[TBL] [Abstract][Full Text] [Related]
4. Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.
Andrich K; Hegenbart U; Kimmich C; Kedia N; Bergen HR; Schönland S; Wanker E; Bieschke J
J Biol Chem; 2017 Feb; 292(6):2328-2344. PubMed ID: 28031465
[TBL] [Abstract][Full Text] [Related]
5. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
[TBL] [Abstract][Full Text] [Related]
6. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
[TBL] [Abstract][Full Text] [Related]
7. Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of Vλ6 proteins associated with AL amyloidosis.
Takahashi D; Matsunaga E; Yamashita T; Caaveiro JMM; Abe Y; Ueda T
Biochem Biophys Res Commun; 2022 Mar; 596():22-28. PubMed ID: 35108650
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin Gallate Remodels Fibrils of Lattice Corneal Dystrophy Protein, Facilitating Proteolytic Degradation and Preventing Formation of Membrane-Permeabilizing Species.
Stenvang M; Christiansen G; Otzen DE
Biochemistry; 2016 Apr; 55(16):2344-57. PubMed ID: 27042751
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.
Franko A; Rodriguez Camargo DC; Böddrich A; Garg D; Rodriguez Camargo A; Rathkolb B; Janik D; Aichler M; Feuchtinger A; Neff F; Fuchs H; Wanker EE; Reif B; Häring HU; Peter A; Hrabě de Angelis M
Sci Rep; 2018 Jan; 8(1):1116. PubMed ID: 29348618
[TBL] [Abstract][Full Text] [Related]
10. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
[TBL] [Abstract][Full Text] [Related]
11. Effect of O-glycosylation on amyloid fibril formation of the variable domain in the Vλ6 light chain mutant Wil.
Abe Y; Shibata H; Oyama K; Ueda T
Int J Biol Macromol; 2021 Jan; 166():342-351. PubMed ID: 33127550
[TBL] [Abstract][Full Text] [Related]
12. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
[TBL] [Abstract][Full Text] [Related]
13. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M
Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552
[TBL] [Abstract][Full Text] [Related]
14. A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer.
Nie RZ; Zhu W; Peng JM; Ge ZZ; Li CM
Biochimie; 2016 Jun; 125():204-12. PubMed ID: 27079519
[TBL] [Abstract][Full Text] [Related]
15. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.
Ferreira N; Cardoso I; Domingues MR; Vitorino R; Bastos M; Bai G; Saraiva MJ; Almeida MR
FEBS Lett; 2009 Nov; 583(22):3569-76. PubMed ID: 19861125
[TBL] [Abstract][Full Text] [Related]
16. Comparison of disaggregative effect of A-type EGCG dimer and EGCG monomer on the preformed bovine insulin amyloid fibrils.
Nie RZ; Zhu W; Peng JM; Ge ZZ; Li CM
Biophys Chem; 2017 Nov; 230():1-9. PubMed ID: 28818314
[TBL] [Abstract][Full Text] [Related]
17. Mechanism for retardation of amyloid fibril formation by sugars in Vλ6 protein.
Abe M; Abe Y; Ohkuri T; Mishima T; Monji A; Kanba S; Ueda T
Protein Sci; 2013 Apr; 22(4):467-74. PubMed ID: 23389799
[TBL] [Abstract][Full Text] [Related]
18. Quinopeptide formation associated with the disruptive effect of epigallocatechin-gallate on lysozyme fibrils.
Cao N; Zhang YJ; Feng S; Zeng CM
Int J Biol Macromol; 2015; 78():389-95. PubMed ID: 25931397
[TBL] [Abstract][Full Text] [Related]
19. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
[TBL] [Abstract][Full Text] [Related]
20. A Substantial Structural Conversion of the Native Monomer Leads to in-Register Parallel Amyloid Fibril Formation in Light-Chain Amyloidosis.
Lecoq L; Wiegand T; Rodriguez-Alvarez FJ; Cadalbert R; Herrera GA; Del Pozo-Yauner L; Meier BH; Böckmann A
Chembiochem; 2019 Apr; 20(8):1027-1031. PubMed ID: 30565364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
